Webinars
May 21, 2025 | 1:00 - 1:45 PM ET
Two additional sessions will be offered: May 22 – 12:00 – 12:45 (UTC +8:00) – Asia/Shanghai May 22 – 12:00 – 12:45 CET – Europe/Berlin
What key insights emerged from the 2024 China National Reimbursement Drug List (NRDL) negotiations and how can they inform strategic go-to-market planning for innovative therapies?
In the 2024 NRDL negotiations, only 28% of submitted products passed expert review, significantly raising the bar for entering pricing negotiations. However, products with robust clinical differentiation or superiority can…
Sign Up Now
Webinars
Available On Demand
Join Value, Access and Pricing experts Max Hunt, Mary Fletcher-Louis and Pinar Bilir as they delve into the emerging role of health equity considerations as a differentiator in value narratives for global HTA (Health Technology Assessment) submissions. NICE’s proposed methods update focused on manufacturer-submitted evidence on health inequalities.This session will explore how HTA agencies are beginning to include health equity in their access recommendations and discuss the practical impact of this trend. Our experts will share insights from Trinity Life…
Watch Now
Webinars
Available On Demand
Today’s launch environment is fraught with greater complexity, lack of standardization and executional inefficiency.
Join Trinity Life Sciences for a virtual “launch and learn” where Krista Perry—Partner & Head of Launch Excellence and Tarra Maeshima— Sr. Director of New Products & Strategy share how Trinity Launch Accelerator enables teams to overcome these typical launch barriers with a simple and clear launch readiness and management process.
Trinity’s Launch Accelerator is the industry’s first and only benchmark-based launch tool, built by experts…
Watch Now
Webinars
White Paper & On-demand Webinar:
This report, the seventh in our Trinity Drug Index series, outlines key themes and emerging trends in the industry as we progress towards a new world of targeted and innovative products. We provide a comprehensive evaluation of the performance of novel drugs approved by the FDA in 2021, scoring each on its commercial performance, therapeutic value and R&D investment.
2021 saw 40 unique drug and biologic approvals, of which ~33% (13/40) were Oncology, followed by…
Read Now
Webinars
Available On Demand
The addition of real-world data (RWD) to other data streams through technology allows the patient impact to be magnified many times. Combined with PMR, RWD can drive exceptional insights and accuracy in demand assessments, segmentation, message testing, market mapping and ATUs. Amplified with GenAI and solutions like Real Insights and RealWorldEDGE, the range of RWD-powered use cases broadens even further.
Join Rajeev Rangachari, CTO of Trinity Life Sciences, as he hosts a wide-ranging discussion on enabling exponential outcomes with RWD…
Watch Now
Webinars
Available On Demand
Join Trinity Life Sciences for a virtual demo where value, access and pricing experts Max Hunt and Andreia Ribeiro will demonstrate Trinity HTA Vision, our cloud-based dashboard with GenAI capabilities.It is not enough to know what the health technology assessment (HTA) decisions are and when they are made—with the landscape continually evolving, analogues and future impact cannot be judged by looking at decisions alone. Nuanced implications come from expert knowledge of countries/agencies, therapeutic areas and lifecycle stage.Discover the power of HTA…
Watch Now
Webinars
Available On Demand
Are you ready to take a bite out of IC administration complexity?
Nothing demotivates a sales team like delayed or inaccurate incentive compensation (IC) calculations and payouts. While administering an IC plan may seem simple to outsiders, seasoned IC administrators know that’s not the case. It takes laser-focused attention to detail and timeliness to manage the constant flow of updates and ensure everything runs smoothly.
Join Trinity Life Sciences for a virtual lunch and learn where IC experts, Miles Scotcher…
Watch Now
Webinars
Available On Demand
There is no room for missteps along the journey to evaluate the viability of assets in early stages of development. When making go/no go decisions, many critical questions must be answered across the early asset lifecycle.Join a team of cross-functional experts from Trinity Life Sciences for a lively panel discussion on how to approach early commercial assessment with insight from various perspectives. The team will share real-life examples highlighting what life sciences companies need to be thinking about and common…
Watch Now
Webinars
Available On Demand
Are you ready for the transition and change being forced on the pharmaceutical industry given the unprecedented Customer Relationship Management (CRM) changes announced by Veeva, Salesforce and IQVIA?
The status quo is not an option. Life science companies are being forced to evaluate the implications on their customer strategy and operations as the CRM is one piece of an increasingly integrated ecosystem. The CRM decision will influence commercial and medical data strategy and management, commercial interface architectures, marketing automation…
Watch Now
Webinars
Available On Demand
Generative AI is having a transformative impact on the pharmaceutical industry. Drugmakers are partnering up with companies like Insilico Medicine, Exscientia, BenevolentAI, and more to leverage their respective generative AI-powered platforms and applying them across the pharma value chain: from accelerating drug discovery and optimizing clinical trials, to improving operational efficiencies and enabling personalized treatments that promise better outcomes.
What progress has been made by the pharma companies in integrating generative AI into their operations and what advances would we…
Watch Now
